VCL and inflammatory bowel disease: This allowed anti-CdtB and anti-vinculin circulating antibodies levels to be used as biomarkers to differentiate IBS-Diarrhea predominant type from inflammatory bowel disease (IBD) in different settings, with promising results [33].